MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Dat-SPECT in multiple system atrophy (MSA)

    I. Toyoshima, T. Hatakeyama, Y. Takeda, K. Obara, M. Kobsysdhi, C. Wada (Yurihonjo, Japan)

    Objective: To evaluate the extent of degeneration in dopamine nerve terminal in striatum with the patients with MSA, and compared between subtypes and disease duration…
  • 2016 International Congress

    Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson’s disease: A prospective study

    T. Kitta, I. Yabe, Y. Kanno, H. Chiba, K. Moriya, I. Takahashi, M. Matsushima, H. Sasaki, N. Shinohara (Sapporo, Japan)

    Objective: The aim of the present study was to determine the effects of istradefylline, adenosine A2A receptor antagonist on lower urinary tract symptoms (LUTS) in…
  • 2016 International Congress

    Prodromal Parkinson’s disease in Argentinean patients with Gaucher disease type 1: Preliminary report

    E.M. Gatto, J.L. Etcheverry, N. Basack, L. Aversa, N. Fernández Escobar, B. Soberón, A. Sanguinetti, M. Cesarini, G. Drelichman, E.M. Gatto (Buenos Aires, Argentina)

    Objective: To describe prodromal symptoms or signs of Parkinson's disease (PD) in a type 1 Gaucher Disease cohort (GD). Background: Mutations in the acid b-glucocerebrosidase…
  • 2016 International Congress

    Hypothalamic volume loss is associated with reduced melatonin output in Parkinson’s disease

    D.P. Breen, C. Nombela, R. Vuono, P.S. Jones, K. Fisher, D.J. Burn, D.J. Brooks, A.B. Reddy, J.B. Rowe, R.A. Barker (Cambridge, United Kingdom)

    Objective: Our aim was to compare hypothalamic volumes in PD patients with matched controls, and determine whether volume loss correlated with reduced melatonin output in…
  • 2016 International Congress

    Pain correlates with sleep disturbances in Parkinson’s disease

    Y. Fu, C. Mao, L. Ma, M. Ding, Y. Wang, C. Liu (Suzhou, People's Republic of China)

    Objective: This study aimed to 1) examine the clinical characteristics of pain in patients with Parkinson's disease(PD) and 2) explore the correlation between pain and…
  • 2016 International Congress

    Depression, anxiety, and apathy in Parkinson’s disease: Insights from neuroimaging studies

    M.C. Wen, L.L. Chan, L.C.S. Tan, E.K. Tan (Singapore, Singapore)

    Objective: (1) To evaluate the existing neuroimaging studies of depression, anxiety and apathy in Parkinson's disease (PD) and (2) to determine the key neural pathway…
  • 2016 International Congress

    The non-motors symptoms in Parkinson’s disease patients with freezing of gait

    H.C. Huang, M.K. Lu, C.H. Tsai (Taichung, Taiwan)

    Objective: To reveal the prevalence of the non-motors symptoms and clinical features differences between Parkinson's disease (PD) patients with and without freezing of gait (FOG).…
  • 2016 International Congress

    Non motor symptoms burden and motor staging of Parkinson’s disease: Evidence for dichotomy and non-motor dominant subtypes from analysis of 249 cases

    K. Ray Chaudhuri, A. Sauerbier, T. Thavayogarajah, A. Rizos, L. Perkins, C. Rodriguez Blazquez, P. Martinez-Martin, On behalf of EUROPAR, the MDS Non-Motor PD Study Group, The NILS Group (London, United Kingdom)

    Objective: To address the co-occurrence of the burden of non-motor symptoms staging (NMSB) and motor severity of Parkinson's disease (PD) using the Hoehn and Yahr…
  • 2016 International Congress

    Allele specificity in neurodegenerative olfactory dysfunction

    B.A. Chase, K. Markopoulou, P. Robowski, A. Strongosky, E. Narozanska, E.J. Sitek, M. Berdynski, M. Barcikowska, M.C. Baker, R. Radamakers, J. Slawek, Z.K. Wszolek (Omaha, NE, USA)

    Objective: Assess olfactory dysfunction in carriers of the p.N279K and p.P301L MAPT mutations, which cause FTDP-17, to understand how genotypic differences contribute to the severity…
  • 2016 International Congress

    Parkinson’s disease is characterised by differences in lower limb joint kinetics during stair ascent and descent

    Z.J. Conway, T.D. Blackmore, P.A. Silburn, M.H. Cole (Brisbane, Australia)

    Objective: To investigate the contribution of the hip, knee and ankle joint moments to support moments during stair ascent and descent in people with Parkinson's…
  • « Previous Page
  • 1
  • …
  • 156
  • 157
  • 158
  • 159
  • 160
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley